14 Comments

BNT162b1 caused high grade Fever in the clinical trial in China, which explains why that country decided not to proceed with mass jabbing.

https://geoffpain.substack.com/p/pfizer-biontech-covid19-jab-multiple

Expand full comment
author

have you found any data for bnt162-06, the mainland b2 trial yet? i find it very interesting that Fosun seems to have insisted on getting in on the BNT162 development with regards to the six shanghai metabolism studies. it should also be considered that millions of fosun doses have been given in hong kong, macau at least. on an unrelated note, it seems HK has nuked it's high-quality english-language covid vaccine dashboard as of nov 12th https://www.coronavirus.gov.hk/eng/dashboard.html, this used to be an interactive, high-detail resource broken down by developer, city district etc.

Expand full comment

PSUR3 says on page 97 Last subject last visit occurred during the reporting interval for BNT162-06 (09 Jan 2022).

Expand full comment
author

wait which part of psur3, p97 here is a hearing loss/tinnitus safety database review https://tkp.at/wp-content/uploads/2023/10/OCR_00.-Comirnaty-AR-PRAC-3-PSUR.pdf

Expand full comment

Of the 702 cases from Clinical trials, 16 cases were from 1 Fosun (BioNTech License Partner) interventional trial (BNT162-06) with BioNTech third

party acting as lead development party.

Expand full comment

PSUR1 says on page 31 that it contains a total of 702 cases from Clinical Trials and 327,125 from post-marketing.

"Clinical Trials cases include cases originated from 6 interventional trials (C4591001, C4591001-OPENLABEL, C4591005, C4591015, C4591017, C4591020) for which Pfizer acts as lead development party, from 3 BioNTech interventional trials (BNT162-01-OPENLABEL, BNT162-01-RN9391R00 and BNT162-04) and from 2 Fosun (BioNTech License Partner) interventional trials (BNT162-03, BNT162-06) with BioNTech third party acting as lead development party."

Page 62 "BNT162-06,26 Safety and immunogenicity of SARS-CoV-2 mRNA vaccine

(BNT162b2) in Chinese healthy subjects: A phase II, randomized, placebo-controlled,

observer-blind study." "No clinically important safety information has emerged from these ongoing clinical trials"

DSUR1 page 55 "BNT162-06 = (NCT 04649021) Phase 2, randomized, placebo controlled, observer-blinded study. (Subjects are randomized: 3 active vaccine to 1 placebo) BNT162b2 P/B (age 18 to 55 yrs): 30 μg 388 Dose 1 / 386 Dose 2

BNT162b2 P/B (age 56 to 85 yrs): 30 μg 330 Dose 1 / 327 Dose 2

Expand full comment
author

notable they have been able to keep the mainland b2 trial under wraps so well for this long. wonder when it started..

Expand full comment

Will delve and report back.

Expand full comment
Nov 14, 2023Liked by modarn_life

Excellent information. Print and keep copies in a safe place.

Expand full comment
Nov 14, 2023·edited Nov 14, 2023Liked by modarn_life

The detection of human DNA and carcinogenic simian virus by Health Canada is another evidence of criminal intent to cull humans:

https://scientificprogress.substack.com/p/system-failure-ai-exposes-zero-government

https://scientificprogress.substack.com/p/depopulation-or-extermination

https://scientificprogress.substack.com/p/depop-vaccines-no-myth

Expand full comment

"However, as the systemic distribution in humans is limited due to i.m. administration..."

Oh really?

Expand full comment
author

The mouse study was i.v. after all - yet for some reason they never got around to doing an i.m.-genotox study

Expand full comment